×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
09:42 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Mizuho from $24.00 to $30.00. They now have an "outperform" rating on the stock.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Mizuho from $24.00 to $30.00. They now have an "outperform" rating on the stock.
12/10
07:21 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/9
08:06 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research.
Medium
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at BTIG Research.
12/8
08:07 am
nrix
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
Low
Report
Nurix Therapeutics (NASDAQ:NRIX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $26.00 price target on the stock.
12/8
08:00 am
nrix
Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
Low
Report
Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
12/6
09:30 am
nrix
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual M
High
Report
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual M
12/2
03:28 pm
nrix
Nurix Therapeutics (NRIX): Assessing Valuation as Investors Await Key NX-5948 Clinical Data Webcast [Yahoo! Finance]
Low
Report
Nurix Therapeutics (NRIX): Assessing Valuation as Investors Await Key NX-5948 Clinical Data Webcast [Yahoo! Finance]
12/1
07:00 am
nrix
Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
Medium
Report
Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition
Date
Time
Symbol
Company Name
Action
%Chg
10/9/2025
04:01 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
-10.1%
nurix therapeutics, inc. - common stock
7/9/2025
04:01 pm
nrix
nurix therapeutics, inc. - common stock
BEAT
Report
-3.9%
nurix therapeutics, inc. - common stock
4/8/2025
04:00 pm
nrix
nurix therapeutics, inc. - common stock
BEAT
Report
3.7%
nurix therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
06:05 am
nrix
Form 8-K Nurix Therapeutics, Inc. For: Dec 06
Medium
Report
Form 8-K Nurix Therapeutics, Inc. For: Dec 06
11/24
06:06 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Nov 24 Filed by: Ring Christine
Low
Report
Form 4 Nurix Therapeutics, Inc. For: Nov 24 Filed by: Ring Christine
11/24
04:27 pm
nrix
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Low
Report
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
11/14
05:03 pm
nrix
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Commodore Capital LP
Low
Report
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: Commodore Capital LP
11/10
07:19 am
nrix
Form 4 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
Low
Report
Form 4 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
11/10
07:18 am
nrix
Form 3 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
Low
Report
Form 3 Nurix Therapeutics, Inc. For: Nov 06 Filed by: DANSEY ROGER D
11/10
07:15 am
nrix
Form 8-K Nurix Therapeutics, Inc. For: Nov 06
Low
Report
Form 8-K Nurix Therapeutics, Inc. For: Nov 06
11/7
11:14 am
nrix
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: FMR LLC
Medium
Report
Form SCHEDULE 13G/A Nurix Therapeutics, Inc. Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: